ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sinovac Biotech Announces Receipt of NASDAQ Letter and Delayed Filing of Annual Report on Form 20-F
May 17, 2017Sinovac Biotech Ltd. announced today that it is delaying its Annual Report on Form 20-F for the year ended December 31, 2016 (the "2016 Annual Report") and that it received a written notice from the Listing Qualifications Department of The Nasdaq Stock Ma
Pharma Sources Insight January 2025
